Lenvatinib plus anti-PD-1 combination therapy for advanced cancers: defining mechanisms of resistance in an inducible transgenic model of thyroid cancer (2022)
- Authors:
- Autor USP: DONADI, EDUARDO ANTONIO - FMRP
- Unidade: FMRP
- DOI: 10.1089/thy.2021.0371
- Subjects: ANTINEOPLÁSICOS; MODELOS ANIMAIS; NEOPLASIAS DA TIREOIDE
- Keywords: Immune checkpoint blockade; Myeloid-derived suppressor cell; T cell activation; Thyroid carcinoma
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: New Rochelle
- Date published: 2022
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BERTOL, Bruna Cristina et al. Lenvatinib plus anti-PD-1 combination therapy for advanced cancers: defining mechanisms of resistance in an inducible transgenic model of thyroid cancer. Thyroid, v. 32, n. 2, p. 153-163, 2022Tradução . . Disponível em: https://doi.org/10.1089/thy.2021.0371. Acesso em: 20 fev. 2026. -
APA
Bertol, B. C., Bales, E. S., Calhoun, J. D., Mayberry, A., Ledezma, M. L., Sams, S. B., et al. (2022). Lenvatinib plus anti-PD-1 combination therapy for advanced cancers: defining mechanisms of resistance in an inducible transgenic model of thyroid cancer. Thyroid, 32( 2), 153-163. doi:10.1089/thy.2021.0371 -
NLM
Bertol BC, Bales ES, Calhoun JD, Mayberry A, Ledezma ML, Sams SB, Orlicky DJ, Donadi EA, Haugen BR, French JD. Lenvatinib plus anti-PD-1 combination therapy for advanced cancers: defining mechanisms of resistance in an inducible transgenic model of thyroid cancer [Internet]. Thyroid. 2022 ; 32( 2): 153-163.[citado 2026 fev. 20 ] Available from: https://doi.org/10.1089/thy.2021.0371 -
Vancouver
Bertol BC, Bales ES, Calhoun JD, Mayberry A, Ledezma ML, Sams SB, Orlicky DJ, Donadi EA, Haugen BR, French JD. Lenvatinib plus anti-PD-1 combination therapy for advanced cancers: defining mechanisms of resistance in an inducible transgenic model of thyroid cancer [Internet]. Thyroid. 2022 ; 32( 2): 153-163.[citado 2026 fev. 20 ] Available from: https://doi.org/10.1089/thy.2021.0371 - DNA damage in patients with acleroderma
- Association of HLA polymorphism and TNF-ALPHA microssatelites with psoriasis in Brazilian patients
- Avaliacao da expressao de moleculas do cph de classe i e ii em diferentes subpopulacoes linfociticas , em funcao da idade
- Behcet syndrome: analysis of 23 casos
- Antigenos e genes de histocompatibilidade na doenca de chagas
- The +3003 callele of the 3’ untranslated region of HLA-G gene is associated with ulcerative colitis in brazilians
- Unusual association of myasthenia gravis , rheumatoid arthritis and basedow-graves disease: hla alleles
- Unusual association of myasthenia gravis , rheumatoid arthritis and basedow graves disease: case report
- Low variability at the HLA-E promoter region in the Brazilian population
- Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse
Informações sobre o DOI: 10.1089/thy.2021.0371 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003265161.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
